Scaling HCP education is not a content problem
Every Medical Affairs and Commercial Excellence team is asked to do the same thing: reach more HCPs, across more specialties and markets, with science that gets more complex and more fragmented every quarter.
The fragmentation is measurable
Biomedical publications grew by more than 200% in twenty years (Ghasemi et al., 2022). That fragmentation makes it harder than ever for HCPs to keep up. And field teams cannot be everywhere.
A PDF, a one-off webinar or a congress booth does not create lasting engagement. So education stays inconsistent, awareness gaps persist, and patients wait longer for the right care.
The harder problem is trust
Volume is the visible problem. It is not the binding one. From your position, you cannot earn HCP trust on your own. That is the constraint every Medical Affairs team works inside, and no amount of content removes it.
Better-informed teams bring more value and credibility to every interaction, giving HCPs more reasons to engage, and re-engage. Credibility is the asset. Content is only the means.
Three questions a clinician asks before reading anything
They are the same in a feed and in a search. Everything we build answers one of them.
1. Is this my subject?
Specialty labels are a poor proxy for practice. Thoracic surgery covers pulmonary, cardiac and vascular work: three activities that do not read the same papers.
- Relevance is set on a practice profile, not on a specialty label
- The product proposes, the clinician confirms in two taps
- All disciplines, 10 languages
2. Is this new to me?
Nothing can be flagged as new without memory of what this clinician has already seen.
- What is read informs what is offered next
- What is asked of the agent comes back into the feed
- The same thread, visit after visit, instead of a session that restarts
3. Is this solid?
This is where transparency is decided, and it covers what a selection leaves out as much as what it surfaces.
- Peer-reviewed journals, predatory journals excluded
- Journal grade, methodological strength, bias analysis, declared interests
- Why a given item was recommended, shown alongside it
- Every figure, every conclusion traces back to the original publication
- Auditable at any time
How this works in practice
Three patterns we see across the Life Science companies we work with. Named examples are available under NDA.
- One market becomes five. A specialty pharma extended a single-country programme across five European markets by localising the scientific content instead of re-creating it, and measuring engagement the same way in each.
- A newsletter becomes an always-on space. Another turned a long-standing email into a persistent space, so updates keep reaching the same targeted HCPs over time rather than once per send.
- A portal that stays current. A third plugs Juisci into its own HCP portal through an API, so the portal publishes new peer-reviewed science every month, market by market, without its teams writing a line.
What this asks of a sponsor
Supporting scientific education is not the same as distributing a message. Three conditions make it credible to an HCP audience.
- Opt-in reach and recurring engagement, rather than an audience bought for the length of a campaign
- Ranking that is never influenced by commercial status. Matching is thematic. A sponsor gains visibility on a theme, never priority over the evidence
- An environment outside medical device scope, with a documentary purpose. Data hosted in the European Union, GDPR. Selection supervised by our medical team
What it comes down to
Scaling HCP education is not about producing more content. It is about delivering the right science to the right HCP, consistently, and being able to measure it.
What matters, and why.
See it on your own therapeutic area
30+ Life Science companies work with Juisci.
.png)
